Mylan's EpiPen Pretax Profits 60% Higher Than Number Told to Congress

Related Link: 

Mylan says that the $100 profit per two-pack of its EpiPen injectors presented by CEO Heather Bresch to Congress last week is actually 60% higher.

A Symbolic Freeze Agreement Won't Revive Oil Prices

Related Link: 

An oil producers’ meeting in Algeria may be surprisingly productive, but there will be little fundamental impact of a freeze on a glutted market.

Corporate-Bond Buying Attracts Doubts as Growth Tool for Europe

Related Link: 

European central banks are looking to corporate debt to help get the region’s economy firing on all cylinders again, but many companies are wary of investing the proceeds from those purchases.

VW Emissions Scandal Claims Audi Executive

Related Link: 

Audi said its head of technical development Stefan Knirsch resigned from the company’s board effective immediately after being challenged on past statements about his knowledge of cheating software.

Major Labels Sue Popular 'Stream Ripping' Website

Related Link: 

The record industry sued one of the most popular sites for converting YouTube music videos into permanent audio files, a fast-growing form of music piracy known as stream ripping.

Messaging Apps Vary Widely When It Comes to Privacy

Related Link: 

With the arrival of Google’s new Allo service, it’s worth looking beneath the hood to see how popular messaging services care for users’ private correspondence.

U.S. Firms Turn to German Training Model to Fill Jobs Gap

Related Link: 

U.S. employers struggling to find enough qualified industrial workers are turning to Germany for a solution to plug the U.S. skills gap: vocational training.

Lands' End CEO Federica Marchionni Is Pushed Out

Related Link: 

Federica Marchionni was forced out as chief executive of Lands’ End, capping a tumultuous 19 months on the job in which she tried to fashion broad changes at the catalog retailer that roiled employees and turned off shoppers.

Nike Can Regain Stride After Results

Related Link: 

Nike’s North American results should begin to accelerate again, as the sportswear maker pushes back against competitors.

Pfizer Throws Out Plan to Split Into Two Companies

Related Link: 

Pfizer said it would remain a single company, deciding not to split into one business focused on patent-protected drugs and another on cash-rich older products.

Syndicate content